iCAD, a global medical technology leader providing innovative enhanced cancer detection and therapy solutions for more than 6,000 facilities worldwide, offers a wide range of powerful tools for clinicians to support cancer detection, while enhancing workflow efficiency. iCAD’s Breast Health Solutions include the ProFound AI platform, a high-performing, concurrent-read workflow solution built on the latest deep-learning artificial intelligence that rapidly analyzes 2D mammography images or tomosynthesis slices to detect malignant soft tissue densities and calcifications with unrivaled accuracy, and PowerLook Density Assessment, which assists radiologists in determining the patient’s appropriate breast density category. This powerful platform is scalable for new applications, including ProFound AI Risk, the first commercially available clinical decision support tool that uniquely combines age, breast density, the presence of masses and calcifications and their asymmetry, resulting in a highly accurate short-term risk estimation that is truly personalized for each woman. For more information, visit www.icadmed.com.


98 Spit Brook Rd Suite 100,
× × × × × × ×